The effects of intravenous ouabain (0.015 mg/kg body weight) were assessed in 13 patients 3-5 weeks after an uncomplicated acute myocardial infarction. The 28.9; peak LV dp/dt, C 1,614 + 141, A 2,145 230; preejection period corrected for heart rate (PEPJ), C 135.8 8.7, A 125.1 + 9.2; left ventricular ejection time corrected for heart rate (LVETC), C 407.9 + 10.3, A 389.5 9.2. These changes were significant (P < 0.05 for paired determinations). There were no significant changes in cardiac index, heart rate, mean arterial pressure, and systemic resistance.
DIGITALIS IN ACUTE MI
stiffened. Although digitalis may increase the force of contraction of the areas of the normal myocardium, it has no effect on the infarcted myocardium and therefore digitalis may not necessarily improve overall ventricular function when the left ventricle is considered as a pump. For example, if the infarcted area is akinetic, digitalis will increase the force of contraction of the normal myocardium, but the damping effect of the bulging ischemic infarcted myocardium may result in no change of LV function. If digitalis improved the impaired LV function in patients convalescing from AMI, this could have therapeutic implications. Therefore, we have assessed LV performance before and after intravenous ouabain in 13 patients 3-5 weeks after AMI.
Methods
Hemodynamic studies were carried out in 13 patients who had recently sustained an acute myocardial infarction. There were eight males and five females; their ages ranged from 52 to 76 years.
Patients were selected for study on the basis of: (1) documented AMI; (2) informed consent being obtained; (3) the patients not receiving digitalis; and (4) the absence of significant complications such as severe arrhythmias and congestive heart failure. Thus the patients did not have paroxysmal nocturnal dyspnea or orthopnea, and they were not dyspneic. Further, they did not have edema, elevated jugular venous pressure, liver enlargement, or rales at the lung bases. The diagnosis of AMI was based on the history of ischemic cardiac pain, appropriate changes in the serum enzymes (serum glutamic oxaloacetic transaminase [SGOT] , lactate dehydrogenase [LDH] , and creatine phosphokinase [CPK] ) , 7 and characteristic alterations of the electrocardiogram (ECG) .8 9 Seven patients were judged to have had a transmural AMI because of the presence of pathologic Q waves on the ECG, and the remaining six patients were considered to have had a nontransmural AMI.
The patients were investigated in the diagnostic cardiac catheterization laboratory. Right atrial (RA) pressure ( LV dp/dt) was recorded from the pressure signal using an R-C differentiating circuit. While such a system is not ideal for recording LV dp/dt, it does provide a practical, useful, and reasonably accurate determination of peak dp/dt.1" Heart sounds were recorded using a contact crystal microphone (Hewlett-Packard model 21050A ,- Mean SEM for left ventricular stroke work (LVSW), left ventricular end-diastolic pressure (LVEDP), mean rate of ejection (MRE), and left ventricular peak dp/dt in the control state and at various intervals after intravenous ouabain infusion. The increases in LVSW, MRE, and LV dp/dt and decreases in LVEDP are significant (P <0.05 for paired determinations).
formula: Abbreviations: C = control state; 1 hr = hour after the end of intravenous ouabain administration; CI = cardiac index; HR = heart rate; SI stroke index; MAP = mean aortic pressure; RA = mean right atrial pressure; Rs = systemic resistance; LVEDP = left ventricular end-diastolic pressure; LVSW = left ventricular stroke work; MRE = mean rate of left ventricular ejection; LV dp/dt = first derivative of left ventricular pressure; PEPC = preejection period corrected for heart rate; LVET. = left ventricular ejection time corrected for heart rate; PEP/LVET = preejectioni period/left ventricular ejection time ratio.
*Units mm Hg U liters/min Blood samples were obtained prior to and at regular intervals after ouabain infusion. Clinical Status of Patients All the patients were making an uncomplicated recovery from recent acute myocardial infarction. One was having some dyspnea on effort. Clinically there was no cardiac enlargement. All 13 patients had an atrial gallop (S4 heart sound). No patient had an apical holosystolic murmur, although three had ejection systolic murmurs (grades I to II/IV). All patients were in normal sinus rhythm. The heart size was normal (cardiothoracic ratio < 0.50) in seven patients, and in the other six patients cardiothoracic ratio was between 0.50 and 0.60. Three patients were receiving diuretics.
Patient Grouping
The patients were distributed into three groups as described previously.1 Group I (patients 1 and 2): CI > 2. 5 , and LVETe (from 407.9 to 389.5 msec). There were significant increases in stroke index (from 35.8 to 39.5 ml/beat/m2), LVSW (from 99.4 to 120.3 g-m), peak LV dp/dt (from 1,614 to 2,145 mm Hg/sec), and MRE (from 237.3 to 274.5 ml/sec). There was a small increase in cardiac index (from 2.72 to 2.9 liters/min/m2) and a small reduction of heart rate (from 79.5 to 77.8 beats/min). all patients and an increase of LVSW in the patients in groups I and II and in one patient in group III; the other patient in group III showed no change in LVSW. Isometric exercise, after intravenous ouabain, resulted in increases in LVEDP and LVSW. Following ouabain administration, the ventricular function curve was moved to the left and upward ( fig. 3 ).
The effects of intravenous ouabain on arterial blood percent 0, saturation, coronary sinus pO2, and CPK in two patients are shown in table 5. There were no significant changes in the variables that were measured. Discussion
Ouabain administration in patients recovering from uncomplicated acute myocardial infarction resulted in reductions in left ventricular end-diastolic pressure, preejection period, and left ventricular ejection time, and increases in stroke index, left ventricular stroke work, peak LV dp/dt, and mean rate of ejection. There were no significant changes in cardiac output or mean aortic pressure and, at the end of 1 hour, there were no significant changes in heart rate, mean right atrial pressure, or PEP/LVET ratio. The left ventricular function curve was moved upward and to the left. Clearly, LV function was improved. Since aortic pressure and heart rate were unchanged, the increase of peak LV dp/dt in association with a reduced LVEDP suggests an increase of myocardial contractility.
Digitalis is an inotropic agent and increases myocardial oxygen consumption (MVO2) .14 Patients with AMI have obstructive coronary artery disease, and the demands for increased MVO2 with ouabain may outstrip the supply, producing further myocardial ischemia. If this occurred, digitalis would be contraindicated. Following intravenous ouabain administration the patients in this study did not complain of angina, there were no ischemic changes on the ECG, the usual hemodynamic accompaniments of spontaneous and exercise-induced angina (increased LVEDP, heart rate, and LVET,; reduced CI, LVSW, and MRE) 15-1S were not seen, and there were no changes in the coronary sinlus blood pO., and CPK concentration in the two patients in whom they were measured. However, it should be stressed that patients considered to have anginal pain were excluded from this study.
Although there was a considerable improvement of LV function with intravenous ouabain, there was no significant increase of cardiac output in these patients. This is not surprising, as the patients were not considered to be in clinical congestive failure and it is known that cardiac output does not increase with digitalis unless there is cardiac failure19 and that cardiac output and the heart's contractile state are not related to one another in a simple manner.20 Although the patients in group III had a reduced CO and an elevated LVEDP, there was no difference in the effects of intravenous ouabain in patients in group II compared with those in group III, suggesting that these patients were not in congestive failure.
In normal subjects ouabain acts directly on the peripheral vessels, resulting in an increase 
